Overview of Boron Neutron Capture Therapy in 2022.
BNCT industry
BNCT manufacturer
accelerator-based neutron sources
boron neutron capture therapy
Journal
Cancer biotherapy & radiopharmaceuticals
ISSN: 1557-8852
Titre abrégé: Cancer Biother Radiopharm
Pays: United States
ID NLM: 9605408
Informations de publication
Date de publication:
Apr 2023
Apr 2023
Historique:
medline:
10
4
2023
pubmed:
29
12
2022
entrez:
28
12
2022
Statut:
ppublish
Résumé
In April 2022, the National Cancer Institute of the United States organized a 3-day seminar, dedicated to boron neutron capture therapy (BNCT). This short article summarizes a presentation from that event, which is intended to provide an overview of activities currently underway worldwide to make BNCT available for patient treatments. This overview does not claim to be exhaustive but shows a great deal of activity in all areas necessary for the complex therapy that is BNCT. A rapid increase in the number of BNCT centers can be expected over the next few years, coupled with the introduction of novel drugs for BNCT. It will be a major challenge to all stakeholders to create clinical networks that can conduct the necessary prospective clinical trials in a short time and in high quality.
Identifiants
pubmed: 36577026
doi: 10.1089/cbr.2022.0072
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM